1 / 10

COMPREHENSIVE CERVICAL CANCER CONTROL C4

COMPREHENSIVE CERVICAL CANCER CONTROL C4. Country: FIJI Presenter: L Volavola. 1. Status of National Programme. Year of starting: Responsible unit: GoF [Ministry of Health] Financing: GoF, AusAID, Merck US Components: Current status: Implementation into routine EPI -2012. 2008-2010.

collin
Download Presentation

COMPREHENSIVE CERVICAL CANCER CONTROL C4

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. COMPREHENSIVE CERVICAL CANCER CONTROLC4 Country: FIJI Presenter: L Volavola

  2. 1. Status of National Programme • Year of starting: • Responsible unit: GoF [Ministry of Health] • Financing: GoF, AusAID, Merck US • Components: • Current status: Implementation into routine EPI -2012 2008-2010

  3. 2. Screening for cervical cancer • Test used: PAP, VIA[ project under UNSW,FNU and FPA] • Coverage:9.6% • Number screened per year: approximately 20,000 • Limitations: number of technicians at 3 divisional labs but now centralised to CWMH, now centralised at National level,non motivated staff-need cytology training

  4. 3. Cancer treatment • Number of centres offering treatment for cervical cancer: 3 divisional plus one private [limited] • Radiotherapy availability: nil • Brachytherapy: nil • Most common stage at presentation:high grade CIN abnormalities(CIN 2 and CIN 3)

  5. 4. Monitoring and evaluation • Cancer registry –yes(Ministry of Health) • Since-2000 • Population covered by cancer registry: National • Incidence rate of cervical cancer-51.3 per 100,000

  6. 5. Challenges and opportunities for cervical cancer control • Challenges: current –TAT for reports from lab; slow uptake of free screening at established health facilities; poor understanding of benefits of early screening [resorting to religious/traditional methods] • Opportunities: strong HPV immunisation program for 9y.o. girls; good partnerships between govt and NGOs with campaigns e.g. Biggest Morning Tea for awareness on prevention and early diagnosis; VIA

  7. 7. HPV vaccination: Decision-making and planning Factors that led to decision to introduce HPV vaccine High burden of disease [Irwin Law 2004] Donation from Merck US to Fiji of 110,000 doses of Gardasil in 2008 Funding sources for vaccine and operational costs: GoF, AusAID [through FHSIP] Vaccine selected: through donation –Gardasil [Merck US]; main serotypes were covered Communications with community, schools, health staff and others to prepare for vaccine introduction: MRIP Campaign

  8. 8. HPV vaccination: Immunization systems Location: school-based program but also from health centres [MCH Clinic]*2008 –parental consent and concern for new vaccine. Staff who administer vaccine: registered nurses System to obtain parental consent: written, signed by parent/guardian Monitoring forms used: yes System for follow-up of absent or missed girls-yes, through register kept at MCH Clinic/school health program but monitored/coordinated by P.O.

  9. 9. HPV vaccination: Challenges in implementation and solutions found Sustainability of funding, support by policymakers –cabinet endorsement of the introduction of HPV as routine in August 2011. Budget of $F1M approved but also includes 2 other new VPDs. Acceptance of (or demand for) HPV vaccination by parents, girls, school and health officials: good acceptance but only over time

  10. 9. HPV vaccination: Challenges in implementation and solutions found Logistics of delivery in schools or other locations: used routine school health program vehicles but also assisted with donor support Attaining high coverage for first dose and complete series: good social marketing campaign; additional doses donated after proposal from GoF to Merck US came in 2009 of 8,000 doses Others: resistance from GP fraternity but MoH responded with offers to speak at mini-conferences; initial resistance from Fiji Cancer Society spokeswoman based on allegations

More Related